Multiomic Health

Next-generation precision medicine

Multiomic, a next-generation precision medicine business, is focusing on tackling conditions related to metabolic syndrome. Multiomic is enabling the development of therapeutics through a unique combination of AI-enabled predictive analytics and biology expertise. The economic impact of metabolic syndrome-related conditions. is currently costing the USA healthcare system $2 trillion.

Through the creation of personalised treatments, Multiomic has the potential to significantly alleviate the financial burden on the healthcare system by addressing these issues.  Multiomic achieves this through identifying unique patient endotypes, re-positioning existing drug candidates, and uncovering novel drug targets,